In IBD, pro-inflammatory CD4+ T cells are not effectively regulated, leading to over-proliferation (91) and excess production of pro-inflammatory cytokines (IFN-γ, TNF-α, and IL-17), which drive inflammation and its exacerbation (92). The gene discussed is CD4; the disease is inflammatory bowel disease.